Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

October 05, 2018 08:58 AM AEST | By Team Kalkine Media
 Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

On 1 October 2018, the Medibio Limited (ASX:MEB) announced that on 28 September it received a notice under Section 249D of the Corporations Act 2001 (Section 249D Notice) requesting the Company call and arrange to hold a meeting of the members of the Company. The Section 249D Notice seeks the appointment of Mr. Benjamin Richardson, Ms. Peta Slocombe, and Mr. Elias Khouri as Directors of the Company and the removal of Mr. Chris Indermaur and Mr. Andrew Maxwell as Directors of the Company. On 5 October 2018, the company released its Investor presentation following which the share price of the company decreased by 1.515%.  [optin-monster-shortcode id="wxhmli4jjedneglg1trq"]

In FY 2018, the company earned a revenue of $2.6 million which was $3.16 million in FY 2017. The Company’s loss increased from $9.78 million in FY 2017 to $16.3 million in FY2018. Resultantly, the basic and diluted loss per share increased from 7.443 cents in FY 2017 to 8.805 cents in FY 2018. Net cash used in operating activities increased from $5.42 million in FY 2017 to $12.27 million in FY 2018. The cash at bank of the company increased from $5.01 million in FY 2017 to $6.12 million in FY 2018. The Company’s ability to continue as a going concern is dependent upon the generation of cash from operations, the sufficiency of current cash reserves to meet existing obligations, research, and development tax incentives, the ability to reschedule planned research and development activity and raising of further equity and receipt of grant funding. The company issued 38,736,640 shares, raising $13,945,190 before issue costs on 20 October 2017 and on 11 October 2017, a total of 10,000,000 options were issued with an expiry of 11 October 2022 and exercise price of 45 cents.

In the past three months, the share price of the company decreased by 56% to $0.066 as on 4 October 2018. The MEB’s share traded at $0.065 with the market capitalization of $13.37 million as on 5 October 2018 (AEST 4:00 PM).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.